The Full ASGCT 27th Annual Meeting Abstracts Collection is NOW LIVE! Click here to read the full collection.
Highlights in the second quarter of 2021 include the approval of a new gene therapy in Japan, the expansion of gene therapy approvals to three new countries, and more!
The second of a new, quarterly publication from ASGCT and Informa Pharma Intelligence, the Gene, Cell, & RNA Therapy Landscape report, is now available! It is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.
Highlights from the second issue include:
Read the Full Report
David M. Barrett, JD, MS is the Chief Executive Officer of the American Society of Gene & Cell Therapy.
May 7-11, 2024 | Baltimore, MD
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico